Combining two active ingredients—afoxolaner and milbemycin oxime—NexGard SPECTRA® offers a convenient solution for canine parasite control. Afoxolaner targets external parasites by over-stimulating their nervous systems, leading to paralysis and death. Milbemycin oxime addresses internal parasites by disrupting neurotransmission, effectively eliminating them. This dual-action formula ensures broad-spectrum efficacy.
| Indications | -Flea Treatment and Prevention: Kills adult fleas and prevents infestations. -Tick Treatment and Control: Effective against various tick species, including the paralysis tick. -Mite Treatment: Addresses demodectic mange, sarcoptic mange, and ear mites. -Heartworm Prevention: Prevents heartworm disease caused by Dirofilaria immitis. -Intestinal Worm Treatment and Control: Effective against roundworms, hookworms, and whipworms. |
|---|---|
| Contraindications | -Not recommended for dogs with a history of seizures or neurological disorders, as isoxazoline class drugs have been associated with such adverse reactions. -Safety has not been established in breeding, pregnant, or lactating dogs. -Not suitable for puppies under 8 weeks of age or weighing less than 2 kg. |
| Dosage | Administer orally once a month, with or without food. Dosage is based on body weight: 2–3.5 kg: 9.4 mg afoxolaner / 1.9 mg milbemycin oxime 3.6–7.5 kg: 18.8 mg afoxolaner / 3.8 mg milbemycin oxime 7.6–15 kg: 37.5 mg afoxolaner / 7.5 mg milbemycin oxime 15.1–30 kg: 75 mg afoxolaner / 15 mg milbemycin oxime 30.1–60 kg: 150 mg afoxolaner / 30 mg milbemycin oxime |
| Storage | -Store below 30°C (86°F). |
| Size | XS, S, M, L, XL |
Be the first to review “NexGard SPECTRA®”
Reviews
There are no reviews yet.